Verrica Pharmaceuticals Inc.

VRCA

VRCAVerrica Pharmaceuticals Inc. US flag

NASDAQ Global Market

5.87

USD

+0.08

- -

62.53MMarket Cap

Income Statement (USD)

API Chat

	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Sales/Revenue/Turnover	- -	- -	- -	- -	- -	12	9	5	8	36
+ Sales & Services Revenue	- -	- -	- -	- -	- -	12	9	5	8	36
- Cost of Revenue	- -	- -	- -	- -	- -	- -	1	1	3	3
+ Cost of Goods & Services	- -	- -	- -	- -	- -	- -	1	1	3	3
Gross Profit	- -	- -	- -	- -	- -	12	8	4	5	32
+ Other Operating Income	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
- Operating Expenses	2	4	22	30	40	43	30	68	71	44
+ Selling, General & Admin	- -	1	9	15	25	27	17	47	59	35
+ Research & Development	2	4	13	15	16	16	12	20	12	9
+ Other Operating Expense	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Operating Income (Loss)	-2	-4	-22	-30	-40	-31	-21	-63	-66	-12
- Non-Operating (Income) Loss	- -	- -	-1	-2	3	4	3	4	11	6
+ Interest Expense, Net	- -	- -	-1	-2	3	4	2	1	8	7
+ Interest Expense	- -	- -	- -	- -	3	4	2	4	9	8
- Interest Income	- -	- -	1	2	1	- -	- -	3	1	1
+ Other Non-Op (Income) Loss	- -	- -	- -	- -	- -	- -	1	3	3	-1
Pretax Income	-2	-4	-21	-28	-43	-35	-24	-67	-77	-18
- Income Tax Expense (Benefit)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
- (Income) Loss from Affiliates	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Income (Loss) from Cont Ops	-2	-4	-21	-28	-43	-35	-24	-67	-77	-18
- Net Extraordinary Losses (Gains)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Discontinued Operations	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Extraord. & Accounting Changes	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Income (Loss) Incl. MI	-2	-4	-21	-28	-43	-35	-24	-67	-77	-18
- Minority Interest	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Net Income, GAAP	-2	-4	-21	-28	-43	-35	-24	-67	-77	-18
- Preferred Dividends	- -	5	- -	- -	- -	- -	- -	- -	- -	- -
- Other Adjustments	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Net Income Avail to Common, GAAP	-2	-10	-21	-28	-43	-35	-24	-67	-77	-18
EBIT	-2	-4	-22	-30	-40	-31	-21	-63	-66	-12
EBITDA	-2	-4	-22	-30	-40	-30	-21	-62	-65	-11
EBITDA Margin (%)	- -	- -	- -	- -	- -	-253.63	-227.83	-1,217.53	-853.38	-31.36
EBITA	-2	-4	-22	-30	-40	-31	-21	-63	-66	-12
Gross Margin (%)	- -	- -	- -	- -	- -	100	91.97	85.44	63.79	90.33
Operating Margin (%)	- -	- -	- -	- -	- -	-257.57	-235.78	-1,233.84	-870.16	-33.56
Profit Margin (%)	- -	- -	- -	- -	- -	-292.33	-271.11	-1,307.47	-1,012.15	-50.27
Sales per Employee	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Dividend per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Depreciation Expense	- -	- -	- -	- -	- -	- -	1	1	1	1
Basic Weighted Avg Shares	2	2	1	2	2	3	3	5	5	11
Basic EPS, GAAP	-0.96	-4.89	-14.08	-11.33	-17.08	-12.97	-7.17	-14.78	-14.78	-1.68
Basic EPS from Cont Ops	-0.96	-2.24	-14.08	-11.33	-17.08	-12.97	-7.17	-14.78	-14.78	-1.68
Diluted Weighted Avg Shares	2	2	1	2	2	3	3	5	5	11
Diluted EPS, GAAP	-0.96	-4.89	-14.08	-11.33	-17.08	-12.97	-7.17	-14.78	-14.78	-1.68
Diluted EPS from Cont Ops	-0.96	-2.24	-14.08	-11.33	-17.08	-12.97	-7.17	-14.78	-14.78	-1.68

Balance Sheet (USD)

API Chat

	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Total Current Assets	1	9	91	65	68	74	39	78	51	43
+ Cash, Cash Equivalents & STI	1	9	90	62	65	70	34	70	46	30
+ Cash & Cash Equivalents	1	9	10	9	11	16	34	70	46	30
+ ST Investments	- -	- -	80	53	55	55	- -	- -	- -	- -
+ Accounts & Notes Receiv	- -	- -	- -	- -	- -	- -	- -	4	- -	5
+ Accounts Receivable, Net	- -	- -	- -	- -	- -	- -	- -	4	- -	5
+ Notes Receivable, Net	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Loans Receivable, Net	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Other Receivable, Net	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Inventories	- -	- -	- -	- -	- -	- -	- -	1	2	2
+ Raw Materials	- -	- -	- -	- -	- -	- -	- -	- -	1	1
+ Work In Process	- -	- -	- -	- -	- -	- -	- -	- -	1	1
+ Finished Goods	- -	- -	- -	- -	- -	- -	- -	- -	1	- -
+ Inventory Adjustments	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Other Inventory	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Other ST Assets	- -	- -	1	3	2	4	4	3	2	5
+ Misc ST Assets	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Prepaid Expenses	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ ST Derivative & Hedging Assets	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ ST Assets Held-for-Sale	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ ST Deferred Tax Assets	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Total Noncurrent Assets	- -	- -	1	3	7	6	6	4	3	5
+ Property, Plant & Equip, Net	- -	- -	- -	2	5	6	5	4	3	2
+ Property, Plant & Equip	- -	- -	- -	2	5	6	6	5	4	3
- Accumulated Depreciation	- -	- -	- -	- -	- -	- -	1	1	1	1
+ LT Investments & Receivables	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ LT Investments	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ LT Receivables	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Other LT Assets	- -	- -	- -	1	2	- -	- -	- -	- -	3
+ Total Intangible Assets	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Goodwill	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Other Intangible Assets	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ LT Deferred Tax Assets	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ LT Derivative & Hedging Assets	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Misc LT Assets	- -	- -	- -	1	2	- -	- -	- -	- -	3
Total Assets	1	9	92	68	74	80	45	82	54	47
+ Payables & Accruals	- -	1	1	2	2	2	2	7	4	4
+ Accounts Payable	- -	- -	1	1	- -	1	1	2	2	2
+ Accrued Taxes	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Interest & Dividends Payable	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Other Payables & Accruals	- -	- -	- -	1	2	2	1	5	2	2
+ ST Debt	- -	- -	- -	- -	36	42	- -	1	14	1
+ ST Borrowings	- -	- -	- -	- -	35	42	- -	- -	13	- -
+ ST Finance Leases	- -	- -	- -	- -	- -	- -	- -	1	1	1
+ Other ST Liabilities	- -	- -	1	1	2	2	1	9	12	11
+ Deferred Revenue	- -	- -	- -	- -	- -	- -	- -	- -	- -	1
+ Derivatives & Hedging	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Deferred Tax Liabilities	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Misc ST Liabilities	- -	- -	1	1	1	2	1	9	12	10
Total Current Liabilities	- -	1	2	3	39	46	3	17	29	16
+ LT Debt	- -	- -	- -	- -	2	1	1	45	32	1
+ LT Borrowings	- -	- -	- -	- -	- -	- -	- -	43	31	- -
+ LT Finance Leases	- -	- -	- -	- -	2	1	1	2	1	1
+ Other LT Liabilities	3	16	- -	- -	- -	- -	- -	- -	3	5
+ Accrued Liabilities	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Pension Liabilities	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Deferred Revenue	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Deferred Tax Liabilities	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Derivatives & Hedging	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Misc LT Liabilities	3	16	- -	- -	- -	- -	- -	- -	3	5
Total Noncurrent Liabilities	3	16	- -	- -	2	1	1	45	35	6
Total Liabilities	3	16	2	3	41	48	5	62	64	22
+ Preferred Equity and Hybrid Capital	3	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Share Capital & APIC	- -	5	123	127	137	172	203	250	297	350
+ Common Stock	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Additional Paid in Capital	- -	5	123	127	137	172	203	250	297	350
- Treasury Stock	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Retained Earnings	-3	-12	-33	-61	-104	-139	-163	-230	-307	-325
+ Other Equity	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Equity Before Minority Interest	-3	-7	89	65	33	33	40	20	-10	25
+ Minority/Non Controlling Interest	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Total Equity	-3	-7	89	65	33	33	40	20	-10	25
Total Liabilities & Equity	1	9	92	68	74	80	45	82	54	47
Shares Outstanding	2	2	3	3	3	3	4	4	9	17
Number of Employees	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Capital Leases - Total	- -	- -	- -	- -	2	2	2	3	2	2
Net Debt	-1	-9	-10	-9	25	26	-34	-27	-2	-30
Net Debt to Equity	19.78	123.04	-11.49	-14.21	74.67	79.56	-85.61	-134.96	24.42	-121.84
Tangible Common Equity Ratio	-1,002.39	-77.52	97.3	95.02	44.48	40.69	89.52	24.22	-18.21	52.5
Current Ratio	1.3	14.75	36.8	19.39	1.71	1.61	11.31	4.55	1.76	2.59
Cash Conversion Cycle	- -	- -	- -	- -	- -	- -	-332.49	108.46	145.43	51.13

Cash Flow Statement (USD)

API Chat

	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
+ Net Income	-2	-4	-21	-28	-43	-35	-24	-67	-77	-18
+ Depreciation & Amortization	- -	- -	- -	- -	- -	- -	1	1	1	1
+ Non-Cash Items	- -	- -	2	2	11	8	7	18	12	6
+ Stock-Based Compensation	- -	- -	2	3	10	6	5	14	7	3
+ Deferred Income Taxes	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Asset Impairment Charge	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Other Non-Cash Adj	- -	- -	- -	-1	1	2	2	3	5	2
+ Chg in Non-Cash Work Cap	- -	- -	1	-2	2	-1	-2	10	2	-6
+ (Inc) Dec in Accts Receiv	- -	- -	- -	- -	- -	- -	- -	-4	4	-5
+ (Inc) Dec in Inventories	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ (Inc) Dec in Prepaid Assets	- -	- -	-1	-2	1	-1	- -	1	-1	- -
+ Inc (Dec) in Accts Payable	- -	- -	2	- -	1	1	-1	13	-1	-1
+ Inc (Dec) in Other	- -	- -	- -	- -	- -	-1	- -	- -	- -	- -
+ Net Cash From Disc Ops	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Cash from Operating Activities	-2	-5	-18	-27	-30	-28	-19	-39	-61	-18
+ Change in Fixed & Intang	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Disp in Fixed & Intang	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Disp of Fixed Prod Assets	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Disp of Intangible Assets	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Acq of Fixed & Intang	- -	- -	-1	-1	-1	-1	- -	- -	- -	- -
+ Acq of Fixed Prod Assets	- -	- -	-1	-1	-1	-1	- -	- -	- -	- -
+ Acq of Intangible Assets	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Cash (Repurchase) of Equity	- -	- -	86	- -	- -	28	27	30	43	50
+ Increase in Capital Stock	- -	- -	86	- -	- -	28	27	30	43	50
+ Decrease in Capital Stock	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Net Change in LT Investment	- -	- -	-79	28	-2	- -	54	- -	- -	- -
+ Dec in LT Investment	- -	- -	- -	118	70	69	59	- -	- -	- -
+ Inc in LT Investment	- -	- -	-79	-90	-72	-69	-5	- -	- -	- -
+ Net Cash From Acq & Div	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Cash from Divestitures	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Cash for Acq of Subs	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Cash for JVs	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Other Investing Activities	- -	- -	- -	-1	- -	- -	- -	- -	- -	- -
+ Net Cash From Disc Ops	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Cash from Investing Activities	- -	- -	-80	26	-4	-1	54	- -	- -	- -
+ Dividends Paid	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Net Cash From Debt	- -	- -	- -	- -	34	5	-88	44	-1	-48
+ Cash From Debt	- -	- -	- -	- -	34	5	- -	44	- -	- -
+ Repayments of Debt	- -	- -	- -	- -	- -	- -	-88	- -	-1	-48
+ Other Financing Activities	- -	13	13	- -	1	1	44	- -	-4	- -
+ Net Cash From Disc Ops	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Cash from Financing Activities	- -	13	99	- -	35	34	-17	74	38	1
Effect of Foreign Exchange Rates	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Net Changes in Cash	-1	8	2	-1	1	5	19	35	-23	-16
EBITDA	-2	-4	-22	-30	-40	-30	-21	-62	-65	-11
EBITDA Margin (%)	- -	- -	- -	- -	- -	-253.63	-227.83	-1,217.53	-853.38	-31.36
Free Cash Flow	-2	-5	-19	-28	-32	-28	-19	-39	-61	-18
Net Cash Paid for Acquisitions	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Free Cash Flow to Firm	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Free Cash Flow to Equity	- -	-13	-19	-28	3	-23	-106	5	-62	-66
Free Cash Flow per Basic Share	-0.81	-2.3	-12.72	-11.28	-12.67	-10.53	-5.55	-8.59	-11.77	-1.65
Price/Free Cash Flow	- -	- -	-0.7	-1.48	-1	-0.93	-0.51	-0.87	-0.06	-5.02
Cash Flow to Net Income	0.84	1.03	0.87	0.97	0.71	0.79	0.76	0.58	0.8	0.99
Capital Expenditures	- -	- -	-1	-1	-1	-1	- -	- -	- -	- -